K Number
K123847
Manufacturer
Date Cleared
2013-01-08

(25 days)

Product Code
Regulation Number
876.1500
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Malleable Tip Endoscopic Applicator is intended for use in delivering hemostatic agents to bleeding surgical sites through a 5 mm or larger trocar.

Device Description

The Malleable Tip Endoscopic Applicator is a sterile, single-use, disposable device intended for delivering a hemostatic agent to bleeding sites. The Malleable Tip Endoscopic Applicator is the identical to predicate with the addition of a malleable tip at the distal end which allows directional placement of hemostatic agents.

The Malleable Tip Endoscopic Applicator cannula and stylet are packaged in a double sterile barrier tray configuration and sterilized using ethylene oxide. Six individually sterile packaged applicators are contained in a shelf carton along with instructions for use. This is the identical packaging configuration as the previously cleared device.

AI/ML Overview

The provided text describes a Special 510(k) Premarket Notification for the Micromedics Malleable Tip Endoscopic Applicator. This submission focuses on design verification and biocompatibility testing for a device that is largely identical to a predicate device, with the addition of a malleable tip.

Here's an analysis of the acceptance criteria and study information:

1. Table of Acceptance Criteria and Reported Device Performance

The submission states that "Non-clinical testing included the tests listed below and showed the test articles met the pre-defined acceptance criteria, therefore demonstrating the mechanical integrity and suitability of the device for its intended use over the labeled shelf life." However, specific acceptance criteria values (e.g., "Leakage rate must be less than X mL/min") and the exact results achieved for each test are not provided in this summary. Only the types of tests performed are listed.

Acceptance Criterion (Type of Test)Reported Device Performance
Leak TestingMet pre-defined acceptance criteria
Particulate TestingMet pre-defined acceptance criteria
Volume TestMet pre-defined acceptance criteria
Cannula Tissue ComplianceMet pre-defined acceptance criteria
Hemostatic Agent Multi-UseMet pre-defined acceptance criteria
Shelf life EvaluationMet pre-defined acceptance criteria
Kink TestMet pre-defined acceptance criteria
Pinch TestMet pre-defined acceptance criteria
Bounce Back TestMet pre-defined acceptance criteria
Flexible Tip StrengthMet pre-defined acceptance criteria
Sterilization ValidationMet pre-defined acceptance criteria
Biocompatibility testing (per ISO 10993-1:2009)Considered safe for use for its intended biocontact.

2. Sample Size Used for the Test Set and Data Provenance

The document does not specify the sample size used for any of the non-clinical tests (e.g., number of devices tested for leak testing, kink testing, etc.).
The data provenance is not explicitly stated in terms of country of origin, but the testing was performed by Micromedics, Inc. (a U.S. company). The testing is non-clinical, meaning it was not performed on human subjects and thus the concepts of "retrospective" or "prospective" human data do not apply.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

This section is not applicable to this submission. The tests are non-clinical, focusing on mechanical and biological properties of the device. There is no human interpretative "ground truth" established by experts in the context of device performance in these tests.

4. Adjudication Method for the Test Set

This section is not applicable as there were no human-interpreted test results requiring adjudication. The tests were objective measurements against pre-defined acceptance criteria.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done

No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. This type of study focuses on comparing human reader performance, typically in diagnostic imaging, which is not relevant to this device's non-clinical safety and performance evaluation.

6. If a Standalone Study (i.e. algorithm only without human-in-the-loop performance) was done

No, this is not an AI/algorithm-based device. The performed studies are standalone in the sense that they evaluate the physical device's performance against specifications, without human interaction with an algorithm.

7. The Type of Ground Truth Used

The ground truth for these non-clinical tests are the pre-defined acceptance criteria for each test. For example, a "kink test" would have a predefined acceptable level of deformation or resistance, and the device's performance is measured against that objective standard. For biocompatibility, the ground truth is compliance with the requirements of ISO 10993-1.

8. The Sample Size for the Training Set

This section is not applicable. There is no "training set" in the context of this device's non-clinical evaluation, as it is not an AI/machine learning device.

9. How the Ground Truth for the Training Set Was Established

This section is not applicable for the same reason as above.

{0}------------------------------------------------

K123847

Micromedics, Inc.

Special 510(k) Premarket Notification Malleable Tip Endoscopic Applicator

510(K) SUMMARY

JAN 8 2013

Date Prepared: December 5, 2012

510(k) SubmitterContact for Official Correspondence
Micromedics, Inc.Jodi L. Raus, MBA, RAC
1270 Eagan Industrial RoadTel: 651-452-1977; Fax: 651-452-1787
St. Paul. MN 55121-1385Email: jodi.raus@nordsonmicromedics.com
General Information
Trade NameMalleable Tip EndoscopicApplicatorCommon NameEndoscopic Applicator
ClassificationInformationEndoscope and accessoriesper 21 CFR 876.1500 (Class II)Product CodeGCJ
PanelGeneral & Plastic Surgery
PredicateDevicesEndoscopic Applicator, K120608 cleared on March 15, 2012360° Gas Assisted Endoscopic Applicator, K122526, cleared on November 16, 2012

Device Description

The Malleable Tip Endoscopic Applicator is a sterile, single-use, disposable device intended for delivering a hemostatic agent to bleeding sites. The Malleable Tip Endoscopic Applicator is the identical to predicate with the addition of a malleable tip at the distal end which allows directional placement of hemostatic agents.

The Malleable Tip Endoscopic Applicator cannula and stylet are packaged in a double sterile barrier tray configuration and sterilized using ethylene oxide. Six individually sterile packaged applicators are contained in a shelf carton along with instructions for use. This is the identical packaging configuration as the previously cleared device.

Intended Use / Indications

The Malleable Tip Endoscopic Applicator is intended for use in delivering hemostatic agents to bleeding surgical sites through a 5 mm or larger trocar

Substantial Equivalence Comparison

The endoscopic applicator subject to this special 510(k) incorporates a flexible tube at the distal end of the applicator which allows for directional positioning of the tip.

{1}------------------------------------------------

Summary of Non-Clinical Performance Data

The Malleable Tip Endoscopic Applicator was evaluated through design verification and biocompatibility testing. Biocompatibility testing performed in accordance with ISO 10993 – Biological evaluation of medical devices, Part 1 – Evaluation and tests (2009) show the device is considered safe for use for its intended biocontact. Non-clinical testing included the tests listed below and showed the test articles met the pre-defined acceptance criteria, therefore demonstrating the mechanical integrity and suitability of the device for its intended use over the labeled shelf life.

  • Leak Testing .
  • Particulate Testing .
  • . Volume Test
  • . Cannula Tissue Compliance
  • Hemostatic Agent Multi-Use .
  • Shelf life Evaluation ●
  • . Kink Test
  • Pinch Test .
  • Bounce Back Test .
  • Flexible Tip Strength .
  • Sterilization Validation .

Substantial Equivalence Conclusion

The Malleable Tip Endoscopic Applicator does not raise new questions of safety or effectiveness when compared to the predicate device and is, therefore, substantially equivalent.

  • The remainder of this page intentionally left blank .-

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is a stylized symbol that resembles an abstract human figure or a caduceus, with three wave-like shapes below it.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

Micromedics, Incorporated % Ms. Jodi L. Raus Director of Regulatory, Clinical and Quality Affairs 1270 Eagan Industrial Road, Suite 120 Saint Paul, Minnesota 55121

January 8, 2013

Re: K123847

Trade/Device Name: Malleable Tip Endoscopic Applicator Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: Class II Product Code: GCJ Dated: December 14, 2012 Received: December 14, 2012

Dear Ms. Raus:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28. 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register_

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

{3}------------------------------------------------

Page 2 - Ms. Jodi L. Raus

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours.

Peter D. Rumm -S

Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Micromedics, Inc.

Special 510(k) Premarket Notification Malleable Tip Endoscopic Applicator

Indications for Use

510(k) Number (if known): ___K123847

Malleable Tip Endoscopic Applicator Device Name:

Indications for Use:

The Malleable Tip Endoscopic Applicator is intended for use in delivering hemostatic agents to bleeding surgical sites through a 5 mm or larger trocar.

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Dwight Yen 2013.01.08 14:01:50 -05'00'

(Division Sign-off) Division of Surgical Devices 510(k) Number K123847

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.